PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Testosterone metabolism in prostatic carcinoma
Article published in Urologia Polska 1982/35/3-4.

authors

Leszek Jeromin
Klinika Urologii Instytutu Chirurgii AM w Łodzi
Dyrektor Instytutu: doc. dr H. Zalech p.o.
Kierownik Kliniki: doc. dr hab. n. med. L. Jeromin

summary

The author believes that serum testosterone concentration in patients With
prostatic carcinoma treated hormonally is of decisive importance for reliable prog-
nosis and for sufficiently early introduction of changes in the therapeutic sche-
dule.

references

  1. Albin R. J., Gonder M. J., Saanes W. A.: Serum proteins in prostatic can­
  2. cer. I. Relationship between clinical stage and level. J. Urol., 1973, 110, 238.
  3. Baranowska B.: Patofizjologia i leczenie zaburzeń hormonalnych w przeroście
  4. gruczołu krokowego. Endokry. Pol., 1978, 6, 544
  5. Bartsh W., Steins P., Becker
  6. H.: Hormone blood levels in patients with prostatic carcinoma and their relation
  7. to the type of carcinoma growth differentation. Eur. Urol., 1977, 3, 47.
  8. Boyns
  9. A. R., Cole E. N., Golder M. P., Denutra V., Harper M. E., Brownsey B., Cowleii T.,
  10. Jones G. E., Griffiths K.: Prolactin studies with the prostate. In prolactin and
  11. carcinogenesis Fourth Tenovus Workshop. Botjns A. R., Griffiths K. (Eds). Cardiff.
  12. 1972.
  13. Dawidowicz A.: Biomolekularne podstawy interakcji hormon ? komór­
  14. ka. PZWL. Warszawa 1975.
  15. Deykin D., Balko C: Recent studies on the me-
  16. chanism of action of testoterone. N. Engl. J. Med., 1972, 287, 1284.
  17. Farns­
  18. worth W. E.: Human prostatic dehydroepiandrosterone sulfate sulfatase. Steroids,
  19. 1973, 21, 647.
  20. Farnsworth W. E., Brown J. R.: Androgen of the human pro­
  21. state. Endocrine Research Communications, 1976, 3, 105.
  22. Habib F. K., Lee I.
  23. R., Stitch S. R., Smith P. H.: Androgen levels in the plasma and prostatic tissues
  24. of patients with benign hypertrophy and carcinoma of the prostate. J. Endocr.,
  25. 1976, 71, 90.
  26. Hafiez A. A., Philpott J. E., Bartke A.: The role of prolactin
  27. in the regulation of testicular function: the effect of prolactin and luteinizing hor­
  28. mone on 3-beta-hydroxysteroid dehydrogenase activity in the testes of mice and
  29. rats J Endocr., 1971, 50, 619.
  30. Hafiez A. A., Lloyd C. W., Bartke A.: The role of prolactin in the regu­
  31. lation of testis function: the effects of eprolactin and luteinizing hormone on the
  32. plasma levels of testosterone and androstenidione in hypophysectomized rats. J.
  33. Endocr., 1972, 52, 327.
  34. Harper M. E., Peeling W. B., Cowley T., Browney B.
  35. G., Phillips M. E. A., Groom G., Fahmy D. R., Griffiths K.: Plasma steroid and
  36. protein hormone concentration in patients with prostatic carcinoma, before and
  37. during oestrogen therapy. Acta Endocr., 1976, 81, 409.
  38. Houghton A. L., Turner
  39. R., Cooper E. H.: Sex hormone binding globulin in carcinoma of the prostate. Brit.J. Urol., 1977, 49, 227.
  40. Kato T., Horton R.: Studies of testosterone binding globulin. J. Clin. Endocr., 1968, 28, 1160.
  41. Kuligowski M.: Rola globuliny wią­żącej sterydy płciowe (SHBG) w przemianie testosteronu do 5- (3-dwuhydrotesto-steronu i androstendiolu w skórze okolicy nadłonowej u kobiet. Endokr. Pol., 1978, 3, 191.
  42. Lasnitzki I., Franklin H. R.: The influence of serum on uptake con-version and action of testosterone in rat prostate glands in organ culture. J. Endo­cr., 1972, 54, 333.
  43. Massa R., Stupnicka E., Kniewald Z., Martini L.: The trans-formation of testosterone into dihydrotestosterone by the brain and the anterior pituitary. J. Steroid Biochem., 1972, 3, 385.
  44. Pirke K. M., Doerr P., Sinter-mann R., Vogt H. J.: Age dependence of testoterone precurosors in plasma of nor­mal adult males. Acta Endocr., 1977, 86, 415.
  45. Prout G. R., Kliman B., Dały J, J., Maclaughlin R. A.: Griffin P. P.: In vitro uptake of 3H testosterone and its conversion do dihydrotestosterone by prostatic carcinoma and other tissues. J. Urol., 1976, 116, 603.
  46. Rubin R. T., Gouin R. P., Lubin A., Poland R. E., Pirke K. M.: Nocturnal increase of plasma testosterone in men: relation to gonadtropins and prolactin. J. Clin. Endocr. Metab., 1975, 40, 1027.
  47. Rudd B. T., Duignan N. M., London D. R.: A rapid method for the measu-rement of sex hormone binding globulin capacity of sera. Clin. Chim. Acta, 1974, 55, 165.
  48. Slaunwhite W. R., Sandberg A. A., Jackson J. E., Staubitz W. J.: Effects of estrogen and HCG on androgen synthesis by human testes. J. Clin. En­docr. Metab., 1962, 22, 992.
  49. Szamatowicz M., Sipowicz I., Sala J.: Pojemność globuliny wiążącej sterydy płciowe (SHB6) w surowicy oraz wydalanie estroge­nów z moczem w zaburzeniach miesiączkowych u dziewcząt. Endokr. Pol., 1979, 1, 89.
  50. Szukalski B., Taracha E.: Mechanizm działania hormonów płciowych ? aspekty patogenetyczne i diagnostyczne. Endokr. Pol., 1977, 28, 479.
  51. Trze-ciak W., Łukaszyk A., Filipiak B.: Rola białek wiążących estrogeny w kontroli hor­monalnej spermatogenezy. Endokry. Pol., 1976, 27, 3.
  52. Wall J. R., Jarrett R. J., Zimmet P. Z., Bailes M., Ramage C. M.: Fali in plasma-testosterone levels in nor­mal male subjects in response to an orał glucose load. Lancet, 1973, 5, 967.
  53. Vermeulen A.: New investigational possibilities in male endocrine hypogona-dism. Organorama 13, 1976, 3, 3.
  54. Voigt W., Castro A.: Androgen and andro­gen receptors in prostatic cancer. Endocrine Control in Neoplasia, Raven Press. New York, 1978.
  55. Yanaikara T., Troen P.: Studies of the human testis I. Biosynthetic pathweys for androgen formation in human testicular tissue in vitro. J. Clin. Endocrin. Metab., 1972, 34, 783.
  56. Zumoff B.: Plasma hormone con-centrations in human breast and prostate cancer. Endocrine Control in Neopla­sia, Raven Press, New York, 1978.